In a recent study in JAMA Network Open, a video storytelling intervention showed promise for helping Hispanic patients with type 2 diabetes reduce their A1C. In a recent randomized clinical trial published in JAMA Network Open, a digital...
Endocrinology
RELEVANT ARTICLES IN ENDOCRINOLOGY
Healthcare Utilization for Cardiovascular Disease in Diabetic Hypothyroidism
Healthcare Utilization for Cardiovascular Disease in Diabetic Hypothyroidism
The following is a summary of “Impact of Hypothyroidism on Cardiovascular-Related Healthcare Utilization in the US Population With Diabetes,” published in the January 2025 issue of Endocrinology by Ramirez et al. Patients with diabetes mellitus (DM) are at an...
Optimizing Spironolactone Use With Sodium Zirconium Cyclosilicate in HFrEF
Optimizing Spironolactone Use With Sodium Zirconium Cyclosilicate in HFrEF
The following is a summary of “Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure,” published in the January 2025 issue of Cardiology by Kosiborod et al. Mineralocorticoid receptor...
Advertisement
Certain Drug Types Associated With Risk for Dementia
Certain Drug Types Associated With Risk for Dementia
TUESDAY, Jan. 21, 2025 (HealthDay News) -- Antimicrobials, vaccines, and anti-inflammatories are associated with a reduced risk for Alzheimer disease and dementia, while antipsychotics and drugs for diabetes are associated with an increased risk, according to a...
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
TUESDAY, Jan. 21, 2025 (HealthDay News) -- For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions, including neurocognitive and cardiometabolic disorders, and...
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
TUESDAY, Jan. 21, 2025 (HealthDay News) -- Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers, including with respect to U.S. Food and Drug Administration approval, according to a...
Healthcare Utilization for Cardiovascular Disease in Diabetic Hypothyroidism
Healthcare Utilization for Cardiovascular Disease in Diabetic Hypothyroidism
The following is a summary of “Impact of Hypothyroidism on Cardiovascular-Related Healthcare Utilization in the US Population With Diabetes,” published in the January 2025 issue of Endocrinology by Ramirez et al. Patients with diabetes mellitus (DM) are at an...
Optimizing Spironolactone Use With Sodium Zirconium Cyclosilicate in HFrEF
Optimizing Spironolactone Use With Sodium Zirconium Cyclosilicate in HFrEF
The following is a summary of “Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure,” published in the January 2025 issue of Cardiology by Kosiborod et al. Mineralocorticoid receptor...
Certain Drug Types Associated With Risk for Dementia
Certain Drug Types Associated With Risk for Dementia
TUESDAY, Jan. 21, 2025 (HealthDay News) -- Antimicrobials, vaccines, and anti-inflammatories are associated with a reduced risk for Alzheimer disease and dementia, while antipsychotics and drugs for diabetes are associated with an increased risk, according to a...
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
TUESDAY, Jan. 21, 2025 (HealthDay News) -- For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions, including neurocognitive and cardiometabolic disorders, and...
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
TUESDAY, Jan. 21, 2025 (HealthDay News) -- Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers, including with respect to U.S. Food and Drug Administration approval, according to a...
Advertisement
Q&A: Identifying an Employment Breach of Contract
Q&A: Identifying an Employment Breach of Contract
Dr. MedLaw addresses physicians' questions regarding medical law, providing guidance in this article to a clinician experiencing employment breach of contract.
Q&A: How to Handle Employment Breach of Contract
Q&A: How to Handle Employment Breach of Contract
Dr. MedLaw addresses physicians' questions regarding medical law, providing guidance in this article to a clinician experiencing employment breach of contract.
Wings of Empowerment: Applying Aviation Wisdom to Patient Journeys
Wings of Empowerment: Applying Aviation Wisdom to Patient Journeys
Lessons drawn from aviation can empower patients, inspiring patient journeys by encouraging them to rise above limits with a bird's-eye view.
CME / CE
Sarcopenia Screening May Reduce CVD Risk in Patients With Type 2 Diabetes
This course discusses sarcopenia screening in patients with type 2 diabetes that appear to be at increased risk for and may develop cardiovascular disease earlier in life than people with type 2 diabetes alone.
PODCAST
Advertisement
MORE STORIES IN ENDOCRINOLOGY
FILTER ARTICLES BY:
Advertisement
PODCAST
CARTOONS
BUSINESS OF MEDICINE
Transfusion Medicine in 2025: Challenges, Innovations, & the Clinicians’ Role in Driving Blood Donation
Transfusion Medicine in 2025: Challenges, Innovations, & the Clinicians’ Role in Driving Blood Donation
ADRP Advisory Board Member Amanda Hess discusses advances in transfusion medicine, challenges blood centers face, and how clinicians can boost blood donation.
Healthcare’s Financial Fault Line: How to Navigate Patient Debt for Improved Health Outcomes
Healthcare’s Financial Fault Line: How to Navigate Patient Debt for Improved Health Outcomes
Rising patient debt strains the US healthcare system, but improving financial assistance, revenue management, and patient engagement can help reduce the burden.
How Flexible Workweeks Could Reduce Physician Burnout & Improve Patient Care
How Flexible Workweeks Could Reduce Physician Burnout & Improve Patient Care
A 4-day workweek may reduce physician burnout, lower costs, improve patient care, and boost work-life balance, benefiting healthcare systems overall.
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.